Lento Bio

📍 Syracuse, United States🗓 Founded 2022👥 3 employees💰 Last funded Dec 2025
Biotechnology Research🌐 lentobio.com
Website LinkedIn
Lento Bio was formed in 2022 in partnership with Ichor Life Sciences, with the goal to develop effective, safe, and durable treatments for chronic age-related disease by using small molecules to directly target molecular damage.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2022
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Lento Bio?
Lento Bio has 1 investors on record on gritt.io, 1 mid-stage.
When did Lento Bio last raise funding?
The most recent investment in Lento Bio recorded on gritt.io was in December 2025.
When was Lento Bio founded?
Lento Bio was founded in 2022.
What industry is Lento Bio in?
Lento Bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Lento Bio based?
Lento Bio is headquartered in Syracuse, United States.